We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$63.4M
AUM Growth
-$59.2M
Cap. Flow
-$60.8M
Cap. Flow %
-95.9%
Top 10 Hldgs %
87.5%
Holding
35
New
–
Increased
–
Reduced
3
Closed
15

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$9.4M
2
ZLAB icon
Zai Lab
ZLAB
+$9.17M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$6.61M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$5.87M
5
SLNO
Soleno Therapeutics
SLNO
+$5.69M

Sector Composition

Rank Sector Weight
1 Healthcare 99.82%
2 Materials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
26
DELISTED
KalVista Pharmaceuticals
KALV
– –
-154,522
Closed -$1.78M
MIRM icon
27
Mirum Pharmaceuticals
MIRM
$6.14B
– –
-146,765
Closed -$6.61M
MRUS
28
DELISTED
Merus
MRUS
– –
-120,038
Closed -$5.05M
PTGX icon
29
Protagonist Therapeutics
PTGX
$9.44B
– –
-121,400
Closed -$5.87M
SLNO
30
DELISTED
Soleno Therapeutics
SLNO
– –
-79,650
Closed -$5.69M
TRML
31
DELISTED
Tourmaline Bio
TRML
– –
-227,090
Closed -$3.45M
VRNA
32
DELISTED
Verona Pharma
VRNA
– –
-147,990
Closed -$9.4M
XENE icon
33
Xenon Pharmaceuticals
XENE
$6.12B
– –
-158,605
Closed -$5.32M
ZLAB icon
34
Zai Lab
ZLAB
$2.62B
– –
-253,675
Closed -$9.17M
CLYM
35
Climb Bio
CLYM
$804M
– –
-463,654
Closed -$566K
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q2 2025 Portfolio in Review

As of Q2 2025, Nan Fung Group Holdings held 35 positions worth $63.4M, down 48% from $123M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Nan Fung Group Holdings withdrew a net $60.8M in Q2 2025, closing 15 positions and reducing 3 holdings. Its most notable exit was Verona Pharma, an estimated $9.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Materials.

  • Nan Fung Group Holdings's biggest Q2 2025 reduction was Replimune Group, cutting an estimated $3.06M.
  • Nan Fung Group Holdings fully exited Verona Pharma in Q2 2025, selling an estimated $9.4M.
  • Nan Fung Group Holdings's ten largest holdings make up 88% of its $63.4M portfolio in Q2 2025.
  • Nan Fung Group Holdings opened 0 new positions and closed 15 in Q2 2025.
  • Nan Fung Group Holdings's portfolio value fell 48% quarter-over-quarter to $63.4M.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.